Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;32:831-837

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Böhm, M.
Right arrow Articles by Zolk, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Böhm, M.
Right arrow Articles by Zolk, O.

(Hypertension. 1998;32:831-837.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Chamber-Specific Alterations of Norepinephrine Uptake Sites in Cardiac Hypertrophy

Michael Böhm; Maurizio Castellano; Markus Flesch; Christoph Maack; Marianne Moll; Martin Paul; Frank Schiffer; ; Oliver Zolk

From the Klinik III für Innere Medizin der Universität zu Köln, Köln (M.B., M.F., C.M., M.M., F.S., O.Z.), and the Institut für Klinische Pharmakologie und Toxikologie der Freien Universität Berlin, Universitätsklinikum Benjamin Franklin, Berlin (M.P.), Germany; and the Scienze Mediche, Universita degli Studi di Brescia, Italy (M.C.).

Correspondence to Michael Böhm, Klinik III für Innere Medizin der Universität zu Köln, Joseph-Stelzmann-Str. 9, 50924 Köln, Germany.

Abstract—The present study investigated local differences of sympathetic activation and sympathetic neuroeffector defects in nonhypertrophied right and hypertrophied left ventricles in a rat model with renin-induced pressure overload [TG(mREN2)27]. As judged from the depletion of myocardial norepinephrine stores, sympathetic activation was more pronounced in the left than in the right ventricles. In addition, norepinephrine uptake1 carrier sites were reduced in left but unchanged in right ventricles. Gene expression of the carrier was unchanged in stellate ganglia. An increase of Gi{alpha} expression and a heterologous adenylyl cyclase desensitization occurred only in the left but not in the right ventricles, whereas a reduction of ß-adrenergic receptors was observed in both chambers. We concluded that general sympathetic activation can lead to ß-adrenoceptor downregulation but that pressure overload further increases sympathetic activation involving norepinephrine uptake mechanisms in the left ventricles, resulting in heterologous ß-adrenergic desensitization.


Key Words: hypertrophy, cardiac • G proteins • adenylyl cyclase • catecholamines




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. A. Wehrwein, L. M. Parker, A. A. Wright, J. M. Spitsbergen, M. Novotny, D. Babankova, G. M. Swain, B. A. Habecker, and D. L. Kreulen
Cardiac norepinephrine transporter protein expression is inversely correlated to chamber norepinephrine content
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R857 - R863.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. M. Raffel, W. Chen, P. S. Sherman, D. L. Gildersleeve, and Y.-W. Jung
Dependence of Cardiac 11C-meta-Hydroxyephedrine Retention on Norepinephrine Transporter Density
J. Nucl. Med., September 1, 2006; 47(9): 1490 - 1496.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. K. Hahn, D. Robertson, and R. D. Blakely
A Mutation in the Human Norepinephrine Transporter Gene (SLC6A2) Associated with Orthostatic Intolerance Disrupts Surface Expression of Mutant and Wild-Type Transporters
J. Neurosci., June 1, 2003; 23(11): 4470 - 4478.
[Abstract] [Full Text] [PDF]